<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01913964</url>
  </required_header>
  <id_info>
    <org_study_id>10/1997</org_study_id>
    <nct_id>NCT01913964</nct_id>
  </id_info>
  <brief_title>Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Catania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Catania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effects of Acetyl-L-Carnitine administration on work productivity, daily
      activity, and fatigue in subjects with chronic hepatitis C treated with
      Pegylated-Interferon-α2b and Ribavirin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1997</start_date>
  <completion_date type="Actual">October 1997</completion_date>
  <primary_completion_date type="Actual">October 1997</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Work Productivity and Activity Impairment in workers with chronic hepatitis C</measure>
    <time_frame>12 months</time_frame>
    <description>Work productivity loss, impairment in daily activities, presenteeism, absenteeism, will be assessed using the Work Productivity and Activity Impairment questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue in workers with chronic hepatitis C</measure>
    <time_frame>12 months</time_frame>
    <description>Severity of fatigue, mental fatigue and physical fatigue.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Work Productivity and Activity Impairment in Workers With Chronic C Hepatitis</condition>
  <condition>Fatigue in Workers With Chronic C Hepatitis</condition>
  <condition>Fatigue</condition>
  <arm_group>
    <arm_group_label>Acetyl-L-carnitine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 g daily for 12 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylcarnitine</intervention_name>
    <arm_group_label>Acetyl-L-carnitine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>(sugar pill)</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  workers who were 18 years of age or older

          -  Workers who were infected by HCV and had a quantifiable serum HCV RNA level (as
             determined by polimerase chain reaction, COBAS AmpliPrep/COBAS TaqMan - ROCHE)

          -  Cirrhotic workers with a Child-Pugh score less than 7

        Exclusion Criteria:

          -  workers who had other liver diseases

          -  cancer

          -  severe jaundice

          -  pulmonary and renal chronic diseases,

          -  prostatic diseases

          -  autoimmune diseases

          -  diabetes mellitus

          -  decompensated cirrhosis

          -  pregnancy

          -  cardiopathy

          -  hemoglobinopathies

          -  hemocromatosis

          -  major depression

          -  severe psychiatric pathological conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2013</study_first_submitted>
  <study_first_submitted_qc>July 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2013</study_first_posted>
  <last_update_submitted>July 31, 2013</last_update_submitted>
  <last_update_submitted_qc>July 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Catania</investigator_affiliation>
    <investigator_full_name>Mariano Malaguarnera</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcarnitine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

